V.-C. Niculescu et al. / Journal of Organometallic Chemistry 700 (2012) 13e19
19
ligands: 0.0088 mg/mL (95% CI: 0.0074e0.0104) for AMNQ and
[4] M.T. Smith, C.G. Evans, H. Thor, O. Sten, Quinones-induced Oxidative Injury to
Cells and Tissues, in: S. Helmet (Ed.), Oxidative Stress, Academic Press Inc,
London, 1985, pp. 91e110.
0
.0022 mg/mL (95% CI: 0.0018e0.0027) for MNBNQ, respectively.
Similar results were reported by Srinivas et al. [18] with
a structurally related naphthoquinone, plumbagin, in human
cervical cancer cell line, ME-180.
[
[
[
[
[
5] E.J. Lee, H.J. Lee, H.J. Park, H.Y. Min, M.E. Suh, H.J. Chung, S.K. Lee, Bioorg. Med.
Chem. Lett. 14 (2004) 5175e5178.
6] G.Y. Song, Y. Kim, X.G. Zheng, Y.J. You, H. Cho, J.H. Chung, D.E. Sok, B.Z. Ahn,
Eur. J. Med. Chem. 35 (2000) 291e298.
7] A.E. Shchekoikhin, V.N. Buyanov, M.N. Preobrazhenskaya, Bioorg. Med. Chem.
12 (2004) 3923e3930.
8] T. Tran, E. Saheba, A.V. Arcerio, V. Chavez, Q.Y. Li, L.E. Martinez, T.P. Primm,
Bioorg. Med. Chem. 12 (2004) 4809e4813.
Ithas beenreportedthat1,2-and 1,4-naphthoquinonesfusedwith
furanorpyranringare importantgroupsforcytotoxicitytocancercell
lines, with 1,2-naphthoquinones having better activity [43].
In these cases, the cytotoxic effect of 1,4-naphthoquinones-
induced cell death was attributed to the induction of apoptosis. Our
data do not allow for a conclusion regarding the mechanisms by
which the new synthesized compounds AMNQ and MNBNQ exer-
ted their cytotoxic effect on L929 and further studies are needed to
elucidate if cell apoptosis or necrosis occurred. Results of a QSAR
study have shown that the cytotoxic activities of 1,4-naph-
thoquinones depend largely on their hydrophobicity [44].
Also, it has been showed the steric interactions of the substit-
uents at either position-2 or position-6 might be also important for
cytotoxic effect [45].
9] J.C. Lien, L.J. Huang, J.P. Wang, C.M. Teng, K.H. Lee, S.C. Kuo, Bioorg. Med. Chem.
12 (1997) 2111e2120.
[
[
[
[
10] E.V. dos Santos, J.W. Carneiro, V.F. Ferreira, Bioorg. Med. Chem. 12 (2004)
87e93.
11] J.A. Valderramma, J. Banites, M. Cortes, H.P. Mahana, E. Prina, A. Fournet,
Bioorg. Med. Chem. 11 (2003) 4713e4718.
12] C.K. Ruy, K.U. Choi, J.Y. Shim, H.J. You, I.H. Choi, M.J. Chae, Bioorg. Med. Chem.
11 (2003) 4003e4008.
13] S.T. Huang, H.S. Kuo, C.J. Hsiao, Y.L. Lin, Bioorg. Med. Chem. 10 (2002)
1947e1952.
[14] V.K. Tandon, R.B. Chhor, R.V. Singh, S. Rai, D.B. Yadav, Bioorg. Med. Chem. Lett.
4 (2004) 1079e1083.
15] V.K. Tandon, R.V. Singh, S. Rai, D.B. Yadav, Bioorg. Med. Chem. Lett. 14 (2004)
901e2904.
1
[
2
[
[
[
16] J.W. Marisco, L. Goldman, PCT Int. Appl. 5 (1975).
17] E.O. Ngo, T.P. Sun, J.Y. Chang, Biochem. Pharmacol. 42 (1991) 1961e1968.
18] P. Srinivas, G. Gopinath, A. Banerji, A. Dinakar, G. Srinivas, Mol. Carcinogen 40
4
. Conclusions
(2004) 201e211.
[
[
[
19] A.L. Balch, F. Rohrscheid, R.H.J. Holm, J. Am. Chem. Soc. 87 (1965) 2301e2302.
20] V.R. Gordeuk, M. Loyevsky, Adv. Exp. Med. Biol. 509 (2002) 251e272.
21] B. Michalke, J. Trace Elem. Med. Biol. 24 (2010) 69e77.
In conclusion, we have synthesized two novel 2,3-disubstituted
1
,4-naphthoquinones and their transitional metal complexes.
Correlation between elementary analysis and physicalechemical
determinations suggests that Pt and Nicomplexes are [ML ] type. The
[22] P. Truitt, F. Mahon, R.L. Hall, T.E. Eris, J. Org. Chem. 25 (1960) 962e964.
[
[
[
[
[
23] E. Block, G. Ofori-Okai, Q. Chen, J. Zubieta, J. Inorg. Chem. Acta 189 (1991)
37e139.
24] J. Yoo, H.-S. Choi, C.-H. Choi, Y. Chung, B.H. Kim, H. Cho, Arch. Pharm. Res. 31
(2008) 142e147.
2
1
coordination is assured by the two sulphur atoms from the “mer-
capto” group and the two nitrogen atoms. ANMQ and NBMNQ are
cytotoxic, but, unfortunately, after complexation with transitional
metal ions this property disappears. In order to correlate the noticed
cytotoxic activity with chemical structure for both ligands and Pt
complex, further physical and chemical studies are mandatory.
25] R.H. Holm, A.L. Balch, A. Davison, A.H. Maki, T.E. Berry, J. Am. Chem. Soc. 89
(1967) 2866e2874.
26] Y.Y. Zheng, S. Saluja, G.P. Yap, M. Blumenstein, A.L. Rheingold, L.C. Francesconi,
Inorg. Chem. 35 (1996) 6656e6666.
27] A.S. Burlov, I.G. Borodkina, L.I. Kuznetsova, A.I. Urae, N. Makarova,
I.S. Vasilchenko, G.S. Borodkin, O. Altun, A.F. Abdullaev, A.D. Garnovskii, Russ.
J. Gen. Chem. 74 (2004) 772e775.
[
28] F. Bretagnol, H. Rauscher, M. Hasiwa, O. Kylian, G. Ceccone, L. Hazell, A.J. Paul,
O. Lefranc, F. Rossi, Acta Biomater. 4 (2008) 1745e1751.
29] M.C. Serrano, R. Pagani, J. Pena, M.T. Portoles, Biomaterials 26 (2005)
5827e5834.
Acknowledgements
[
We are grateful to University from Craiova for allowing us using
its instruments and laboratories. Authors want to bring a post-
mortem tribute to Professor PhD Viorica Muresan, who shared her
knowledge in coordination chemistry and spectra interpretation.
[
[
30] R. Zange, T. Kissel, Eur. J. Pharm. Biopharm. 44 (1997) 149e157.
31] G. Faria, C.R. Cardoso, R.E. Larson, J.S. Silva, M.A. Rossi, Toxicol. Appl. Phar-
macol. 234 (2009) 256e265.
[32] M. Nordin, A. Wieslander, E. Martinson, P. Kjellstrand, Toxicol. In Vitro 5
1991) 449e450.
(
[
[
[
33] T. Taniguchi, M. Shimizu, H. Nakamura, T. Hirabayashi, H. Fujino,
Appendix
T. Murayama, Eur. J. Pharmacol. 546 (2006) 1e10.
34] B. Roelofs, A. Tidball, A.E. Lindborg, A.T. Harmsel, T.O.V. Kooy, L.L. Louters,
Biochimie 88 (2006) 1941e1946.
Marvin was used for drawing, displaying and characterizing
35] M. Cartwright, S. Martin, S. D’Mello, G. Heinrich, Brain Res. Mol. Brain Res. 15
(1992) 67e75.
2
[36] F. Freshney, Culture of Animal Cells: A Manual of Basic Technique, fifth ed.
John Wiley and Sons, New Jersey, 2005.
[
[
37] R Development Core Team, R: A Language and Environment for Statistical
Appendix. Supplementary material
[
[
39] K.A. Jensen, P.H. Nielsen, Acta Chem. Scand. 20 (1966) 597e629.
40] E. Pretsch, P. Buhlmann, M. Badertscher, Structure Determination of Organic
Compounds, Springer-Verlag, Berlin, 2009.
References
[41] H.B. Gray, C.J. Ballhausen, J. Am. Chem. Soc. 85 (1963) 260e268.
[42] L.G. Vanquickenborne, K. Pierloot, Inorg. Chem. 20 (1981) 3673e3677.
[43] N. Kongkathip, B. Kongkathip, P. Siripong, C. Sangma, S. Luangkamin,
M. Niyomdecha, S. Pattanapa, S. Piyaviriyagul, P. Kongsaeree, Bioorg. Med.
Chem. 11 (2003) 3179e3191.
[
[
[
1] B.H. Kim, J. Yoo, S.H. Park, J.K. Jung, H. Cho, Y. Chung, Arch. Pharmacal Res. 29
2006) 123e130.
2] P. Babula, V. Adam, L. Havel, R. Kizek, Ceská a Slovenská Farmacie 56 (2007)
14e120.
3] M.M. Shi, A. Kugelman, T. Iwamoto, L. Tian, H.J. Forman, J. Biol. Chem. 269
1994) 26512e26517.
(
1
[
[
44] R.P. Verma, Anticancer Agents Med. Chem. 6 (2006) 489e499.
45] R.P. Verma, C. Hansch, Bioorg. Med. Chem. 12 (2004) 5997e6009.
(